Lilly(Eli) & Company
NYSE: LLY
$748.91
-$8.69 (-1.1%)
Real Time Data Delayed 15 Min.
LLY Articles
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Published:
Last Updated:
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aetna, Baker Hughes, Chesapeake Energy, Cognizant Technology Solutions, Cummins, Eli Lilly, General Electric, Qualcomm...
Published:
Last Updated:
Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the...
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo and Roku.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang for their buck. There were a couple major IPOs this week that lived up to the hype...
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.